These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27794110)

  • 1. The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21.
    Steele HE; Horvath R; Taylor RW
    Neurology; 2016 Nov; 87(22):2286-2287. PubMed ID: 27794110
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
    Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
    J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.
    Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA
    Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome.
    Garrido-Pérez N; Vela-Sebastián A; López-Gallardo E; Emperador S; Iglesias E; Meade P; Jiménez-Mallebrera C; Montoya J; Bayona-Bafaluy MP; Ruiz-Pesini E
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype.
    Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A
    Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
    Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
    Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
    Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
    Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mitochondrial stress on systemic metabolism.
    Lee MS
    Ann N Y Acad Sci; 2015 Sep; 1350():61-5. PubMed ID: 26100439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of FGF21 in atherosclerosis pathogenesis.
    Tabari FS; Karimian A; Parsian H; Rameshknia V; Mahmoodpour A; Majidinia M; Maniati M; Yousefi B
    Rev Endocr Metab Disord; 2019 Mar; 20(1):103-114. PubMed ID: 30879171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
    Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
    Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Thyfault JP; Rector RS
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G832-43. PubMed ID: 27012775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 in chronic kidney disease.
    Suassuna PGA; de Paula RB; Sanders-Pinheiro H; Moe OW; Hu MC
    J Nephrol; 2019 Jun; 32(3):365-377. PubMed ID: 30430412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAP finds FGF21 easy to digest.
    Gillum MP; Potthoff MJ
    Biochem J; 2016 May; 473(9):1125-7. PubMed ID: 27118870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling.
    Ribas F; Villarroya J; Hondares E; Giralt M; Villarroya F
    Biochem J; 2014 Oct; 463(2):191-9. PubMed ID: 25055037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
    Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
    J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment.
    Arlien-Søborg MC; Grøndahl C; Bæk A; Dal J; Madsen M; Høgild ML; Pedersen SB; Bjerre M; Jørgensen JOL
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31544947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
    Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
    EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
    Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
    EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.